nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A Biparatopic HER2-Targeting Antibody-Drug Conjugate Induces Tumor Regression in Primary Models Refractory to or Ineligible for HER2-Targeted Therapy
|
Li, John Y. |
|
2016 |
29 |
1 |
p. 117-129 13 p. |
artikel |
2 |
A Designed Inhibitor of p53 Aggregation Rescues p53 Tumor Suppression in Ovarian Carcinomas
|
Soragni, Alice |
|
2016 |
29 |
1 |
p. 90-103 14 p. |
artikel |
3 |
An Integrated Metabolic Atlas of Clear Cell Renal Cell Carcinoma
|
Hakimi, A. Ari |
|
2016 |
29 |
1 |
p. 104-116 13 p. |
artikel |
4 |
GSK3 Deficiencies in Hematopoietic Stem Cells Initiate Pre-neoplastic State that Is Predictive of Clinical Outcomes of Human Acute Leukemia
|
Guezguez, Borhane |
|
2016 |
29 |
1 |
p. 61-74 14 p. |
artikel |
5 |
Long-Term ERK Inhibition in KRAS-Mutant Pancreatic Cancer Is Associated with MYC Degradation and Senescence-like Growth Suppression
|
Hayes, Tikvah K. |
|
2016 |
29 |
1 |
p. 75-89 15 p. |
artikel |
6 |
MiR-215 Is Induced Post-transcriptionally via HIF-Drosha Complex and Mediates Glioma-Initiating Cell Adaptation to Hypoxia by Targeting KDM1B
|
Hu, Jing |
|
2016 |
29 |
1 |
p. 49-60 12 p. |
artikel |
7 |
Parsing Myc Paralogs in Oncogenesis
|
Mathsyaraja, Haritha |
|
2016 |
29 |
1 |
p. 1-2 2 p. |
artikel |
8 |
Polycomb Repressive Complex 2 Is a Barrier to KRAS-Driven Inflammation and Epithelial-Mesenchymal Transition in Non-Small-Cell Lung Cancer
|
Serresi, Michela |
|
2016 |
29 |
1 |
p. 17-31 15 p. |
artikel |
9 |
Targeting Aberrant Epigenetic Networks Mediated by PRMT1 and KDM4C in Acute Myeloid Leukemia
|
Cheung, Ngai |
|
2016 |
29 |
1 |
p. 32-48 17 p. |
artikel |
10 |
The Interaction of Myc with Miz1 Defines Medulloblastoma Subgroup Identity
|
Vo, BaoHan T. |
|
2016 |
29 |
1 |
p. 5-16 12 p. |
artikel |
11 |
Venetoclax Adds a New Arrow Targeting Relapsed CLL to the Quiver
|
Rogers, Kerry A. |
|
2016 |
29 |
1 |
p. 3-4 2 p. |
artikel |